AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model.
Verhelle A, Nair N, Everaert I, Van Overbeke W, Supply L, Zwaenepoel O, Peleman C, Van Dorpe J, Lahoutte T, Devoogdt N, Derave W, Chuah MK, VandenDriessche T, Gettemans J.
Verhelle A, et al. Among authors: peleman c.
Hum Mol Genet. 2017 Aug 1;26(15):3030. doi: 10.1093/hmg/ddx207.
Hum Mol Genet. 2017.
PMID: 28605435
No abstract available.